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Abstract
It has recently been shown that nucleosome distribution, histone modifications and RNA polymerase II (Pol II) occupancy
show preferential association with exons (‘‘exon-intron marking’’), linking chromatin structure and function to co-
transcriptional splicing in a variety of eukaryotes. Previous ChIP-sequencing studies suggested that these marking patterns
reflect the nucleosomal landscape. By analyzing ChIP-chip datasets across the human genome in three cell types, we have
found that this marking system is far more complex than previously observed. We show here that a range of histone
modifications and Pol II are preferentially associated with exons. However, there is noticeable cell-type specificity in the
degree of exon marking by histone modifications and, surprisingly, this is also reflected in some histone modifications
patterns showing biases towards introns. Exon-intron marking is laid down in the absence of transcription on silent genes,
with some marking biases changing or becoming reversed for genes expressed at different levels. Furthermore, the
relationship of this marking system with splicing is not simple, with only some histone modifications reflecting exon usage/
inclusion, while others mirror patterns of exon exclusion. By examining nucleosomal distributions in all three cell types, we
demonstrate that these histone modification patterns cannot solely be accounted for by differences in nucleosome levels
between exons and introns. In addition, because of inherent differences between ChIP-chip array and ChIP-sequencing
approaches, these platforms report different nucleosome distribution patterns across the human genome. Our findings
confound existing views and point to active cellular mechanisms which dynamically regulate histone modification levels
and account for exon-intron marking. We believe that these histone modification patterns provide links between chromatin
accessibility, Pol II movement and co-transcriptional splicing.
Citation: Dhami P, Saffrey P, Bruce AW, Dillon SC, Chiang K, et al. (2010) Complex Exon-Intron Marking by Histone Modifications Is Not Determined Solely by
Nucleosome Distribution. PLoS ONE 5(8): e12339. doi:10.1371/journal.pone.0012339
Editor: Anton Wutz, Wellcome Trust Centre for Stem Cell Research, United Kingdom
Received October 15, 2009; Accepted July 14, 2010; Published August 23, 2010
Copyright:  2010 Dhami et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The Wellcome Trust (http://www.wellcome.ac.uk/); The National Institute for Health Research in England (http://www.nihr.ac.uk/Pages/default.aspx);
The National Human Genome Research Institute (http://www.genome.gov/) Grant No: U01HG003168; Ministry of Education, Czech Republic Grant
No.6007665801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: dlv1q@clinmed.gla.ac.uk
. These authors contributed equally to this work.
¤a Current address: University College London Cancer Institute, University College London, London, United Kingdom
¤b Current address: Department of Molecular Biology, Faculty of Science, University of South Bohemia, Ceske Budejovice, Czech Republic
¤c Current address: School of Genetics and Microbiology, Moyne Institute of Preventative Medicine, Trinity College, Dublin, Ireland
¤d Current address: EMBL – European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, United Kingdom
Introduction
It is a widely held view that combinations of post-translational
modifications on the N-terminal tails of histones are likely to
function as an epigenetic code [1] to regulate aspects of gene
expression, including the activity of cis-regulatory elements, and
the three phases of transcription (initiation, elongation and
termination). In support of this code, systematic studies of histone
acetylation and methylation patterns across the human genome
have revealed signatures for transcriptionally active and inactive
promoters [2,3,4,5,6], distal elements/enhancers [2,4,6], and
insulators [2,7]. A number of these histone modifications have
also been shown to co-localize with gene bodies of transcribed
genes [2,5,8]. Until recently, the extent to which modifications in
gene bodies contribute to the functional complexity of chro-
matin is not clear. Evidence pointed to H3K9ac, H3K9me2,
H3K27me3, and H3K36me3, having roles in closing chromatin to
prevent spurious initiation of transcription within gene bodies
[9,10,11], and/or facilitating splicing [12,13,14]. What is clear is
that expressed genes require a dynamic equilibrium between
the relaxation and compaction of chromatin [15], and the
displacement/replacement of nucleosomes [16,17] as the RNA
polymerase II (Pol II) complex moves through the gene during
transcription [18].
The recent discovery that H3K36me3 marks exons within
transcribed gene bodies provided the first genome-wide evidence
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that coding features of all expressed genes may also have specific
epigenetic signatures related to co-transcriptional splicing [12].
Subsequently, a number of studies provided clues as to the extent
of this marking; a large number of histone modifications showed
higher levels across exons which, for the most part, could be
accounted for by nucleosome distribution, with well-positioned
nucleosomes on exons accounting for these patterns [19,20,
21,22,23]. Higher levels of Pol II occupancy were also associated
with exons when compared to introns [19], suggesting that Pol II
movement is affected by nucleosome positioning. However, the
exact relationships between histone modifications, nucleosome
distribution, Pol II movement and splicing across transcribed
genes are not yet clear, although recent evidence points to a role
for H3K36me3 in regulating the splicing machinery [24].
In this context, we sought to more accurately define the
distribution of a variety of histone modifications within gene
bodies across the human genome across several cell types, and
relate these patterns to hallmarks of transcriptional activity and
chromatin structure. Our data further supports the existence of a
complex chromatin-based marking system for exon-intron struc-
tures across the human genome. Histone modifications are
primarily associated with exons, but some also show higher levels
in introns. Surprisingly, this exon-intron marking is intrinsic to
most genes, irrespective of their transcriptional status, although the
type of marks found on transcriptionally active or inactive genes
do differ. We provide evidence that this marking is not accounted
for by nucleosome distribution and points to active mechanisms
which lay down these marks across exons or introns of both
expressed and non-expressed genes. Our data supports the
hypotheses that histone modifications may regulate chromatin
accessibility and Pol II movement during transcription and co-
transcriptional splicing, and may also ‘‘prime’’ exon-intron
structures prior to transcription.
Results
Histone Modifications Mark Exon-Intron Structures of
Expressed and Non-expressed Genes in a Cell-type
Specific Manner
We performed chromatin immunoprecipitation in combination
with microarrays (ChIP-chip) for 19 histone modifications, Pol II,
histone density, and chromatin accessibility (FAIRE) in two
hematopoietic cell lines (erythroid K562 and monocytic U937)
and primary CD14+ monocytes. FAIRE (formaldehyde-assisted
isolation of regulatory elements) assays allow DNA segments which
are less readily cross-linked with proteins after formaldehyde
treatment (i.e., regions of accessibility or DNase I hypersensitivity)
to be physically separated from bulk cross-linked chromatin using
phenol-chloroform fractionation [25,26]. We analyzed the output
of these assays, in the first instance, on our bespoke (custom-made)
tiling path microarray covering 30 Mb of the human genome
constituting the pilot regions of the ENCODE project [4]. The
ENCODE pilot regions have been shown to be strong indicators of
trends across the whole genome [3]. In parallel, we determined
expression profiles for our three cell types (see Materials and
Methods). To account for non-specific enrichments from ChIP
and differences in nucleosome density, we normalized our datasets
with the non-specific antisera ChIP profiles [27] and for H3/H2B
histone density. This normalization step would effectively remove
any biases in histone modification profiles which could be
attributed to differences in nucleosome distribution. We deter-
mined the distribution of histone modifications with respect to the
‘‘ON/OFF’’ expression status of genes, their overall chromatin
landscape, and exon/intron structures. We subsequently profiled
four of these histone modifications across the whole human
genome (see below).
Consistent with our previous observations and with those of
others [2,4,5], we found four generalized trends for histone
modifications across consensus plots for expressed genes in all
three cell types (Supplementary Figures S1, S2, S3, S4). These
included histone modifications with a substantial promoter/
transcriptional start site (TSS) bias (e.g. H3K4me2 and
H3K4me3), those extending into gene bodies with either a 59 or
39 enrichment biases relative to gene structures (e.g. H3K79me3
and H3K36me3 respectively), and those depleted across gene
bodies (e.g. H3K36me1). Non-expressed genes showed hallmark
patterns of enrichment for the repressive modifications (e.g.
H3K9me2 and H3K27me3). Patterns for histone density and
FAIRE were consistent with open, nucleosome-poor and closed,
nucleosome-rich chromatin states for expressed and non-expressed
genes respectively (Supplementary Figure S5).
We analyzed further the co-localization of these histone
modifications with respect to features within gene bodies. Initially,
we combined data from all three cell types, in order to observe
generalized trends of histone modification patterns which may
reflect fundamental features of eukaryotic cells. We constructed
consensus exon-intron plots across the ten most 59 exons (to
represent 59 ends and gene bodies) and across the five most 39
exons (to represent 39 ends) of genes. Thus, unlike previous studies,
we examined histone modification levels across the entire lengths
of exons and introns rather than exclusively around the exons and
their most immediate 59 and 39 intronic sequences. This allowed
us to assess whether, on average, differences in histone
modification levels could discriminate exons from introns across
their entire lengths. For transcriptionally active (i.e., expressed)
genes, we found patterns of differential ‘‘marking’’ of exons when
compared to introns for 15 of the 19 histone modifications
(Figure 1; Supplementary Figure S6). The majority of these biases
(seen for 10 out of 15 modifications) were evident as enrichments
favoring exons. These included H3K36me3 which had previously
been reported as preferentially marking exons [12,19,20,
21,22,23]. Others, such as H3K9me2, H3K9me3, H3K27me2
and H3K27me3 were evident as selective depletions across exons.
One modification, H3K36me1, showed an enrichment bias
favoring introns. Surprisingly, non-expressed genes also showed
consistent patterns of exon-intron marking for five modifications
with some modifications having enrichment biases favoring exons
(e.g. H3K27me3) while others showed biases favoring introns (e.g.
H3K9me2) (Supplementary Figures S7). At 39 ends of expressed
genes, the differential marking of exons and introns was
maintained up to the penultimate exon, after which the differential
was less obvious or absent (Supplementary Figure S7). For virtually
all histone modifications, the marking biases we observed were
evident both with and without nucleosome normalization
(Figure 1; Supplementary Figures S6 and S7), demonstrating that
underlying nucleosome distributions could not account for the
differential marking levels we observed. Furthermore, in several
instances, marking biases were accentuated only through nucle-
osome normalization (Figure 1 and Supplementary Figure S6, eg.
H3K36me1; Supplementary Figure S7a and c, eg. H3K27ac),
providing evidence that nucleosome distributions could mask
underlying differences in histone modification levels if not taken
into account.
Overall, these marking patterns (both normalized and unnor-
malized with respect to nucleosome distributions) showed high
levels of statistical significance (see Figures 1, Supplementary
Figures S6, S7) when compared with randomized datasets of
histone modification enrichments and when comparing enrich-
Exon-Intron Marking
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ments found on exons with those of introns - demonstrating that
the marking patterns and biases were directed specifically at exons
or introns within the genome. These distributions could not be
accounted for by variations in GC-content [12] which may affect
hybridization kinetics in ChIP-chip assays, since we observed
histone modification biases both for exons and for introns
(although exons generally have a higher GC-content than introns).
Furthermore, nucleosome normalization would take into account
any GC-content related effects. Thus, we attributed our results as
indicative of a complex bona fide marking system of exon-intron
structures defined by histone modification levels and not by
nucleosome distributions, as reported previously [19,20,21,22,23].
The complexity of this marking system was further elaborated
when we examined histone modification exon-intron marking
biases for each of the three cell types independently (Supplemen-
tary Figure S8). We identified a high degree of variability in the
marking repertoire of each cell type – with one or two cell types
showing exon bias for a given histone modification, while the third
cell type showing the opposite (i.e., intronic) or no exon-intron bias
at all. Only eight modifications showed consistent biases across all
three cell types and, even then, only showed these biases in the
context of expression (i.e., either for expressed and/or non-
expressed genes). For expressed genes in all three cell types,
H3K36me3 was the only mark showing strong enrichment bias for
Figure 1. Histone modification patterns track exons and introns across gene bodies which is not accounted for by nucleosome
distribution. Histograms show the mean levels of ChIP-chip enrichments (Z-scores) for 15 histone modifications spanning the first ten exons and
nine introns of expressed consensus genes (n = 268, exons:introns = 1466:551). Data is derived from ENCODE regions in the K562 and U937 cell lines
and CD14+ primary monocytes. Datasets were normalized with the combined histone distribution profiles obtained for H2B and H3 in each cell line.
Some of these modifications showed the most obvious exon marking over the first two 59 exons (eg., H3K9ac and H3K4me3), while others showed
differential enrichments across the majority of the first ten exons (eg., H3K27me1 and H3K36me3), apart from the first two. Repressive modifications
H3K9me2/3 and H3K27me2/3 showed preferential depletion of exons, while H3K36me1 showed preferential enrichment of introns. Hypothetical
gene structures are shown at the bottom of the figure. Median P-value obtained from bootstrapping for exons and introns across all 19 histone
modifications tested in this study was ,1.0610215. Median P-value obtained for pair-wise t-tests between adjacent exon-intron pairs (exon2 R
exon10) for the data shown in the figure was 3.54610
25.
doi:10.1371/journal.pone.0012339.g001
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exons, with H3K9me2, H3K9me3, H3K27me2 and H3K27me3
showing consistent exonic depletion. For non-expressed genes,
H3K9me2 and H3K9me3 showed intronic enrichment,
H3K27me3 showed exonic enrichment, while H3K36me1,
H3K9ac and H3K18ac all showed intronic depletion. Cell-type
specific differences in marking biases were not due to inherent
differences between the epigenetic states of cell lines and primary
cells, since K562 showed as many concordant marking biases with
CD14+, as it shared with U937 (Supplementary Table S1).
Variations in Nucleosomal Architecture Between Cell
Types
We further explored the underlying nucleosomal landscape
across the three cell types to determine why our ChIP-chip histone
modification patterns were not accounted for by nucleosome levels
as shown in previous studies using ChIP-sequencing [19,20,22,28].
For this analysis, we also performed ChIP-seq in the K562 cell line
to determine whether we observed the same nucleosomal patterns
with both ChIP-chip and ChIP-seq platforms. By examining
nucleosomal levels across exons and introns of expressed genes, we
observed striking variations in the three cell types analyzed by
ChIP-chip (Figure 2). Both K562 and U937 displayed higher levels
of nucleosomes in introns, while CD14+ cells showed higher levels
across exons. This not only highlighted that different cell types
may have different nucleosomal architectures, but reinforced that
nucleosome distributions did not account for, and were often
opposing, exon-intron marking by histone modifications (Supple-
mentary Figure S8). Remarkably, in our analysis of nucleosome
density in K562 using ChIP-seq, we saw a distinct bias in
nucleosome distribution favoring exons which was in direct
contrast to the patterns observed with ChIP-chi. This nucleosomal
exon bias was seen for the set of expressed genes in ENCODE
regions which we had analyzed by ChIP-chip, and also genome-
wide for all expressed genes in K562. These results not only
provide compelling evidence that ChIP-chip and ChIP-seq reveal
different nucleosomal architectures, but also helped reconcile the
differences in marking patterns which we observed with ChIP-chip
from that which others observed with ChIP-seq [19,20,22,28].
While ChIP-chip is likely to capture the entire chromatin milieu of
cells, size-selection of ChIP-seq material may only capture a
proportion of the information which is obtained from ChIP assays.
This interpretation is supported by studies which have shown than
sonication of cross-linked chromatin followed by massively-parallel
sequencing of size-selected material, enriches for regions of high
chromatin accessibility [29]. Such enrichment would also apply to
sequencing of ChIP samples derived by either cross-linking
followed by sonication, or by native ChIP using micrococcal
nuclease digestion, as both procedures are unlikely to fragment the
genome randomly prior to chromatin immunoprecipitation.
Therefore, we believe that our ChIP-chip datasets accurately
reflect marking of exons and introns (by both nucleosomes and
histone modifications) in the cell types we analyzed.
Evidence for the Combinatorial Nature of Exon-Intron
Marking
It is thought that the co-occurrence of histone modifications on
the same histone tails could function combinatorially as a ‘‘histone
code’’ to regulate biological outcomes [1]. To provide evidence for
the combinatorial nature of exon-intron marking, we addressed
whether histone modifications could exist together on the same
histone tails by performing sequential-ChIP on ENCODE
microarrays (seq-ChIP-chip). We used permutations of histone
modifications which showed concordant marking biases in K562
cells in either expressed or non-expressed genes (H3K36me3
followed by H3K27me1 - both favoring exons of expressed genes;
H3K27me3 followed by H3K36me1 - both favoring exons of non-
expressed genes). These combinations showed improved resolution
of exon-intron marking after seq-ChIP-chip for either expressed or
non-expressed genes which could not be accounted for by
nucleosome distribution (Supplementary Figure S9 and S10). To
provide evidence that our seq-ChIP-chip procedure resulted in
enrichments coming from both ChIPs when assayed sequentially,
we also performed two control seq-ChIP-chip experiments. The
first (H3K27me1 followed by H3K36me3) showed that our seq-
ChIP-chip could detect enrichments irrespective of the order that
the ChIP assays were performed. The second was used to show
that when two histone modifications with opposing types of
tracking (one favoring exons and one favoring introns across
expressed genes) were used in seq-ChIP-chip, the resultant
sequential profiles showed an overall loss or reversal of tracking
which was no longer statistically significant (Supplementary
Figures S9 and S10). Our data suggests that there is combinatorial
marking of exons with H3K27me1/H3K36me3 or H3K27me3/
H3K36me1 within gene bodies of expressed or non-expressed
genes respectively. However, whether these signatures occur
together on the same histone H3 N-terminal tail, or on the same
or closely spaced nucleosomes cannot be determined from our
assays. Previous sequential-ChIP analysis had shown that a
H3K27me3/H3K4me3 ‘‘bivalent’’ signature is likely to exist on
the same histone tails at the 59 ends of a subset of developmentally
regulated genes which are either silent or have low levels of
transcriptional activity [2,30]. The exon marking signatures we
describe here span entire gene bodies of either expressed or non-
expressed genes, and may thus be typical signatures of all genes.
Furthermore, these combinations provide a tantalizing clue that
there may be a ‘‘combinatorial switch’’ - (H3K27me3 R
H3K27me1 and H3K36me1 R H3K36me3), when a gene goes
from being repressed to being active.
Exon-Intron Marking Reflects Exon Usage
We next examined the possible functions of this histone
modification marking system. H3K36me3 marking, among others,
had previously been implicated in co-transcriptional splicing with
enrichment biases showing a relationship with exon usage (i.e.,
favoring canonical exons rather than alternatively-spliced exons
across expressed genes) [12], splice-site strength [19,20,23] or splice-
site switching [24]. For all expressed and non-expressed genes
identified in K562, U937 and CD14+ cells, we examined the mean
enrichment levels of each of the 19 histone modifications across a
total of 3761 canonical exons and compared them with the levels
attributed to alternatively-spliced exons and introns (totals of 1064
and 4626 respectively). We considered that any biases at 59 ends of
coding sequences may be distinct from those across gene bodies, as
they lie within close proximity to promoters which have unique
histone modification signatures. Thus, we partitioned our datasets
accordingly with the 59-most 25% of gene lengths being considered
separately from the remainder of gene bodies. We observed
extensive exon usage biases within gene bodies (Figure 3, Supple-
mentary Figure S11). In gene bodies of expressed genes, 13 histone
modifications mirrored exon usage as either enrichment or depletion
biases, depending on whether the marking favored exons or introns.
In these cases, alternatively-spliced exons showed mean values which
lay between those found for canonical exons and those for introns –
as would be expected, given that only a proportion of alternatively-
spliced exons would be used in the cell types we examined. Exon
usage biases were further accentuated in sequential-ChIP-chip assays
for combinations of H3K36me3 and H3K27me1 in the K562 cell
Exon-Intron Marking
PLoS ONE | www.plosone.org 4 August 2010 | Volume 5 | Issue 8 | e12339
line (Supplementary Figure S10). This data supports previous
findings linking exon-intron marking by histone modifications with
co-transcriptional splicing, although our evidence would suggest that
at least 13 histone modifications are involved in this process (at least
two of which may act in specific combinations on expressed genes).
However, six modifications did not show alternatively-spliced exons
having mean enrichments between those of canonical exons and
introns for expressed genes (e.g. H3K79me1R3, H4K16ac). This, in
addition to the data which showed exon or intron biases for histone
modifications across non-expressed genes (Figure 1 and Figure 3)
suggests that other features, apart from exon usage, are being
marked across gene structures. Furthermore, given that cell-type
specific exon-intron marking also exists (Supplementary Figure S8),
the relationship between histone modifications and splicing may also
have cell-type specific components.
RNA Polymerase II Occupancy is Linked to Chromatin
Accessibility and Histone Modification Patterns
Previous studies have linked Pol II occupancy with nucleosome
positioning, suggesting that the nucleosome per se, may provide a
Figure 2. Nucleosome distribution patterns in three cell types display different biases with respect to exon-intron structures in
gene bodies of expressed genes. Histograms show the mean levels of ChIP-chip enrichments (Z-scores) or mean number of reads (ChIP-seq) for
histones spanning the first ten exons and nine introns of consensus expressed genes. a. K562 cell line using ChIP-chip (n = 76, exons:introns
= 477:187). b. U937 cell line using ChIP-chip (n = 88, exons:introns = 558:219). c. CD14+ primary monocytes using ChIP-chip (n = 80, exons:introns
= 493:181). d. K562 cell line using ChIP-seq (n = 68, exons:introns = 465:418). e. K562 cell line using ChIP-seq (n = 1184, exons:introns = 8095:7500).
Data was derived as the combined dataset for H2B and H3 across the ENCODE regions (panels a R d) or across the whole genome (panel e).
Hypothetical gene structures are shown at the bottom of each panel of the figure. Median P-values obtained from bootstrapping for exons and
introns were 1.77610213 (panel a), ,1.0610215 (panel b), 5.93610211 (panel c), ,1.0610215 (panel d) and ,1.0610215 (panel e). Median P-values
obtained for pair-wise t-tests between exons and introns (exon2 R exon10) were 4.14610
24 (panel a), 1.87610213 (panel b), 2.33610216 (panel c),
3.21610210 (panel d) and ,1.0610215 (panel e).
doi:10.1371/journal.pone.0012339.g002
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barrier or ‘‘speed bump’’ which impedes Pol II movement across
exons which have well-positioned nucleosomes [19,31]. However,
given that these studies were conducted using ChIP-seq, we
considered that they may not provide a completely unbiased view
of the role of chromatin architecture in regulating Pol II
movement. We adopted a view that exon-intron marking by
histone modifications, at least for expressed genes, may also be
involved in regulating chromatin accessibility to facilitate the
movement of Pol II across genes during transcription. Therefore,
we examined whether other features of chromatin structure across
expressed genes also displayed exon-intron marking which were
concordant with histone modification patterns. We had already
demonstrated that the densities of histones H2B and H3 (i.e.,
nucleosomes) were lower across exons than introns of expressed
genes in both the K562 and U937 cell lines, but the patterns were
reversed in CD14+ monocytes (Figure 2). FAIRE accessibility
assays showed the highest levels of accessibility across introns of
both expressed and non-expressed genes in all three cell types
(Supplementary Figure S12). Therefore, the different nucleosome
distributions in our three cell types could not explain the FAIRE
patterns, confounding views that nucleosome patterns per se
determine accessibility. However, eight histone modifications
(H3K9me2, H3K9me3, H3K9ac, H3K27ac, H3K27me2,
H3K27me3, H3K36me1, and H3K36me3) consistently showed
differential exon-intron marking across all three cell types (see
above and Supplementary Figure S8) which were concordant with
the FAIRE profiles for either expressed or non-expressed genes.
This pointed to these histone modifications being directly related
to accessibility across gene bodies.
This suggested to us that the combinatorial effect of differential
histone modification load across gene bodies may result in an
overall more compact chromatin configuration across exons of
expressed genes. From this, we predicted that although K562 and
U937 both have higher nucleosome densities in introns than in
exons, Pol II occupancy across exons would be higher than across
introns. Our prediction was substantiated by observing significant
exon bias in Pol II occupancy across expressed genes in K562 and
U937 when we performed ChIP-chip assays with an antibody
which recognized both initiating and elongating forms of Pol II
(Figure 4 and Supplementary Figure S13). This bias reflected exon
usage and showed highest levels of occupancy at both 59 and 39
ends of genes. Unlike histone modification profiles which
differentially marked exon-intron structure across genes up to
the penultimate exon (Supplementary Figure S6), marking by Pol
II appeared to continue right up to the last exon.
Taken together, our data points towards a close relationship
between chromatin accessibility/compaction, histone modifica-
tions and the movement or ‘‘pausing’’ [32] of Pol II across exon-
intron structures during transcriptional elongation. In turn, Pol
II exon ‘‘pausing’’ may affect exon usage during co-transcrip-
tional splicing. In support of our interpretations, data from a
variety of sources suggests that histone modifications [12,24,33],
histone deacetylase and chromatin modelling activity [34,35,36]
and the speed of Pol II movement or pausing [37,38,39] may
facilitate splice-site selection in alternatively-spliced mRNAs.
This would imply that the role of histone modifications in co-
transcriptional splicing is not direct, as suggested previously
[12,24]. While it is possible that well-positioned nucleosomes
across exons are also related to Pol II movement [19], cues
received by Pol II from histone modifications on these
nucleosomes may be the critical factor in controlling both Pol
II movement and the recruitment of splicing factors. Our data is
consistent with histone modifications having both of these roles,
as has been proposed by other investigators [31]. Furthermore,
differences in marking between histone modifications and Pol II
at the 39 ends of expressed genes suggest that there are other
Figure 3. Histone modifications differentially mark canonical and alternatively-spliced exons and introns across bodies of
expressed genes. Histograms show the mean levels (Z-scores) for histone modifications and histones (ChIP-chip enrichments) or chromatin
accessibility (FAIRE) spanning typical canonical/alternatively-spliced exons and introns. Data was derived from gene bodies of expressed genes
(n = 268, canonical exons:alternatively-spliced exons:introns = 2463:523:3036) in the K562 and U937 cell lines and CD14+ primary monocytes across
the ENCODE regions. Histone distribution was based on the combined data for H2B and H3 in each cell type. Biases favoring either canonical exon or
intron are summarized by the difference in Z-scores shown above each assay in grey. Positive (+) differences in Z-scores reflect exon biases, while
negative (2) differences reflect intron biases. Error bars are 95% confidence intervals.
doi:10.1371/journal.pone.0012339.g003
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features involved in pausing during polyadenylation [40,41] that
we have not yet examined.
Exon-Intron Marking is Dependent on Rates of
Transcription
We were able to determine that the exon-intron marking
patterns we had observed across the ENCODE regions were
fundamental features of all human genes by performing ChIP-chip
using Affymetrix GeneChIPH whole genome tiling arrays. These
studies were performed in the K562 cell line for four modifications
(H3K27me1, H3K27me3, H3K36me1 and H3K36me3) which
typified the kind of exon or intron marking biases we had observed
across the ENCODE regions, and which appeared to be
distributed as combinatorial signatures in either expressed or
non-expressed genes (see Results above and Supplementary
Figures S9 and S10). We examined histone modification patterns
across the gene structures of 9921 genes for which we had
consistent expression data, and gene/transcript information
available from ENSEMBL (see Materials and Methods). For both
expressed and non-expressed genes, we observed genome-wide
patterns of exon-intron marking that were in agreement with those
we obtained across the ENCODE regions (Figure 5A, Supple-
mentary Figures S14, S15). We did, however, observe that
similarities between the ENCODE and whole genome datasets
were most evident when we explored different binning strategies
for expressed and non-expressed genes. For example, for
H3K27me1, the top 25% of expressed genes in genome-wide
analysis showed patterns similar to the ENCODE regions (Figure 1
and Figure 5a), whilst only the bottom 10% of non-expressed
genes genome-wide showed the same patterns obtained for
ENCODE. This suggested that different rates of transcription
reflected in steady-state expression levels may have a bearing on
the marking system. By constructing 12 intervals of modification
data based on the Robust Multichip Average (RMA) values of all
9921 genes, we uncovered striking differential exon/intron
marking as a function of expression level (Figure 5b, c) displaying
a number of prominent features.
Firstly, the most repressed/silent genes (the first decile in
Figure 5a) were not appreciably enriched for these four histone
marks. Secondly, substantial enrichments for the repressive
H3K27me3 were the first to appear in the second and third
deciles, followed thereafter by the other three modifications as
‘‘waves’’ of increasing and then decreasing enrichment levels, in
the order H3K36me1, H3K27me1 and H3K36me3. Genes within
deciles 1 to 4, however, were still transcriptionally inactive, as we
could not detect appreciable levels of Pol II binding for 24 genes
assayed by ChIP-chip which were partitioned into these deciles
(data not shown). Thirdly, exons were preferentially loaded with
modifications at lower levels of expression, with introns only
showing similar levels of enrichments at higher levels of expression
(shown as an intron ‘‘lag’’ in Figure 5c). The marking biases at
canonical or alternatively-spliced exons differed as a function of
expression level, and in some instances, showing higher enrich-
ments for alternatively-spliced exons than for canonical ones (e.g.
H3K36me1 and H3K27me1), again suggesting that exon usage per
se was not the only factor that distinguished them. Fourthly, at the
Figure 4. RNA polymerase II (Pol II) occupancy levels are increased at transcribed exons. a. Pol II levels across consensus expressed (‘‘ON’’)
(n = 245) and non-expressed (‘‘OFF’’) genes (n = 115). b. Histograms show levels of Pol II at 59 ends and across gene bodies with respect to canonical/
alternatively-spliced exons and introns of expressed genes [n = 181, canonical exon:alternatively-spliced exon:intron = 330:151:496 (59 ends) or 1705/
371/2110 (gene bodies)]. Biases favoring either canonical exon or intron are summarized by the difference in Z-scores shown above each assay in
grey. Positive (+) differences in Z-scores reflect exon biases, while negative (2) differences reflect intron biases. Error bars are 95% confidence
intervals. c. Exon-intron tracking of Pol II across the first ten exons and nine introns of consensus expressed genes (n = 181, exon:introns = 980:376)
(hypothetical gene structure shown below panel). d. Exon-intron tracking of Pol II across last 5 exons and 4 introns of consensus expressed genes
(n = 181, exon:introns = 563:148) (hypothetical gene structure shown below panel). Median P-values obtained from bootstrapping for exons and
introns in c and d were both,1.0610215. Median P-values obtained for pair-wise t-tests between adjacent exon-intron pairs in data from c (exon2R
exon10) and in d (exonslast-4R exonlast) were 5.06610
26 and 6.3061024 respectively. In all panels, Pol II ChIP-chip enrichments across ENCODE genes
in the K562 and U937 cell lines are expressed as mean Z-scores.
doi:10.1371/journal.pone.0012339.g004
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very highest levels of expression (the top 5-10% of RMA values,
decile 10), the marking biases and enrichment levels of all four
modifications showed distinct shifts away from those seen in the
previous deciles. More specifically, (i) marking biases for both
H3K36me1 and H3K27me3 switched from favoring exons, to
favoring introns, and (ii) the differentials between canonical exons,
alternative exons and introns for all four modifications changed.
We further refined the nature of some of these shifts by examining
the predicted level of inclusion of alternatively-spliced exons in
gene transcripts expressed at high levels. H3K36me3 levels
showed enrichments which reflected exon usage, with frequently
included alternatively-spliced exons having higher modification
levels than infrequently included ones (Supplementary Figure
S16). Surprisingly, H3K36me1, H3K27me1 and H3K27me3 all
showed significantly higher levels of enrichments for less frequently
included exons, supporting the idea that exon exclusion, rather
than exon inclusion or usage, was also a feature of the marking
system. This last feature points to a specialized need to further
regulate chromatin structure and Pol II movement at very high
rates of transcription – this may be required to maintain the
fidelity of transcriptional elongation or the splicing process.
Exon-Intron ‘‘Priming’’ in the Absence of Transcription
We propose that the ‘‘waves’’ of differential exon-intron
marking with histone modifications described above could model
the temporal events that occur when genes go from being
transcriptionally repressed/silent to being transcriptionally active.
For individual genes which were differentially expressed between
the three cell types we examined, we confirmed that changes in
expression from non-expressed to expressed (‘‘OFF’’ to ‘‘ON’’) or
from low expression to high expression were accompanied by the
changes predicted for these four histone modifications (Supple-
mentary Figure S17). All of our data, taken together, suggests that
such a model has both transcriptionally-independent (‘‘priming’’)
and transcriptionally-dependent phases (Figure 6). Furthermore, in
both of these phases, histone modification marking distinguishes
Figure 5. Genome-wide histone modifications patterns track exon-intron structures in gene bodies according to levels of gene
expression or repression. a. Histograms show the level of four histone modifications across the first ten exons and nine introns of consensus
genes expressed (‘‘ON’’) (n = 1845, exons:introns = 12763:10853) or non-expressed (‘‘OFF’’) (n = 1657, exon:introns = 10911: 9194). Exon numbering is
at the bottom of the panel. Median P-value obtained from bootstrapping for exons and introns for all four modifications were ,1.0610215 (‘‘ON’’)
and ,1.0610215 (‘‘OFF’’). Median P-values obtained for pair-wise t-tests between adjacent exon-intron pairs (exon2R exon10) for the data shown in
the figure were 1.01610249 (‘‘ON’’) and 6.48610209 (‘‘OFF’’). b. Histograms show relationships between four histone modifications and canonical/
alternatively-spliced exons, and introns across gene bodies as a function of expression levels (percentile rankings on the x axes). Genes (n = 9921,
canonical exons:alternatively-spliced exons:intron = 70470:20733:91613) were ranked into 12 bins according to expression level (percentile rankings
on the x axes). Error bars are 95% confidence intervals. c. Line graphs of the levels of the four histone modifications from b as a function of expression
level (percentile rankings on the x axes) and exon/intron structure (red = canonical exons, blue = alternative exons and green = introns). Error bars
are 95% confidence levels. In all panels, ChIP-chip enrichments obtained from genome-wide analysis of the K562 cell line are expressed as mean Z-
scores.
doi:10.1371/journal.pone.0012339.g005
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canonical exons from alternatively-spliced exons, both of which
are seen as distinct from introns. Based on our whole genome
analysis, ‘‘priming’’ of exons and introns is likely to involve
H3K27me3 and H3K36me1, both of which appear loaded onto
histones when genes are silent or at low levels of gene expression.
These modifications are removed in favor of H3K27me1 and
H3K36me3 as expression levels increase. This would indicate that
the switch from the tri- to mono-methyl state for H3K27 and the
switch from the mono- to tri-methyl state for H3K36 may be
involved in the transition from ‘‘priming’’ to transcription, or from
low-level to high-level transcription. This idea is also supported by
our sequential-ChIP-chip which showed that the combination
H3K27me3/H3K36me1 is found on non-expressed genes,
whereas expressed genes have H3K36me3/H3K27me1 (Supple-
Figure 6. Schematic model of the relationships between histone modifications and exon-intron structures across expressed and
non-expressed/silent genes. Model is based on relationships observed for both ENCODE and whole genome datasets described in the text.
Circular arrows reflect statistically significant increases (+) or decreases (2) in histone modification levels (shown either side of the arrows) observed
when comparing a typical intron and a typical exon (either canonical or alternative) in either the expressed (‘‘ON’’) or non-expressed (‘‘OFF’’) state.
Relative distances between nucleosomes are based on histone density data. Predicted Pol II movement is also shown. Transcribed mRNA is shown in
red. a. Canonical exon versus intron. b. Alternatively-spliced exon versus intron.
doi:10.1371/journal.pone.0012339.g006
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mentary Figures S9 and S10). The presence of exon-intron
marking for H3K9me2 or 3 and H3K27me2 across non-expressed
genes (Figures 1 and 3) argues that a variety of repressive marks
are also involved in the ‘‘priming’’ process. Noticeably, these latter
marks show biases favoring introns, which is in contrast to the
exon enrichment bias seen with H3K27me3. Therefore, the
‘‘priming’’ process may be capable of distinguishing the full
complement of coding features (both exons and introns) in the
absence of transcription. We speculate that ‘‘priming’’ may
provide a transcription-ready template of exon-intron structures,
and that this template serves to facilitate subsequent phases of
marking and chromatin re-organization during transcription. This
model, which is consistent with data from one other study [23],
confounds previous views that histone modification patterns across
gene bodies are found only on transcribed genes [12,19,20] and
points to exon-intron marking as a constitutive feature of
eukaryotic genes irrespective of transcriptional activity.
Discussion
There is a growing body of evidence linking chromatin structure
and function, exon-intron organization and co-transcriptional
splicing/mRNA processing (reviewed in [31,42]). Our study
provides several lines of evidence pointing to histone modifications
as having roles in determining chromatin accessibility, Pol II
movement and co-transcriptional mRNA processing at a global level
through exon-intron marking. Our results are in striking contrast to
previous reports which showed that histone modification exon-
intron marking patterns were merely a reflection of nucleosomal
distribution, with well-positioned nucleosomes on exons accounting
for apparent histone modification biases [19,20,21,22]. Having
accounted for differences in nucleosome distribution, the patterns of
histone modifications we observed can only be attributable to active
cellular mechanisms (i.e., the action of histone modifiers) which
overlay the nucleosomal architecture with modifications on specific
nucleosomes located within exons or within introns. Furthermore,
while other studies had observed exon marking across expressed
genes by analyzing a single cell type, our data points to aspects of this
marking as being cell-type specific, combinatorial, and related to
levels of transcription – with even untranscribed genes having exon-
intron marking biases. We also provide evidence that this marking
system is not simply mirroring exon usage, as some modifications
track infrequently used alternative exons. These observations have
not been fully described previously.
What remains to be determined are how each histone
modification contributes to chromatin configurations and the
control of Pol II movement, which trans-acting factors lay down
the marks, and whether the marks facilitate recruitment of
additional factors during the three phases of transcription, and
during co-transcriptional splicing. Whether aspects of this marking
system function in a truly combinatorial fashion must be explored
further. Given our evidence which shows exons are ‘‘primed’’ with
histone marks prior to their transcription, how this ‘‘priming’’ is
laid down in the absence of Pol II, and whether it is
developmentally regulated are particularly interesting areas to
explore. The findings of the present study confound previous views
on chromatin and splicing and provide the starting point for
several new avenues of investigation.
Materials and Methods
ENCODE Tiling Array
The construction of the PCR product Sanger Institute
ENCODE array is described in detail elsewhere [4]. This array
was further supplemented with a 256 kb tiling path of the human
SCL locus for which a detailed analysis of histone modifications
had previously been determined [43]. The preparation of
amplicons and arrays are also described at www.sanger.ac.uk/
Projects/Microarrays/arraylab/methods.shtml.
Cell Sources
Human cell lines K562 [44] and U937 [45] were cultured in
DMEM, 9% fetal calf serum, 1% penicillin-streptomycin and
2 mM L-glutamine and in RPMI 1640, 18% fetal calf serum, 1%
penicillin-streptomycin and 2 mM L-glutamine respectively.
Human CD14+ monocytes were isolated from peripheral blood
obtained from a subject of the Cambridge BioResource, a
collection of 4000 pseudo-anonymized healthy blood donors that
has been established by the Cambridge Biomedical Research
Centre in collaboration with NHS Blood and Transplant, for use
in genotype-phenotype association studies. The study was
approved by the Cambridgeshire 1 Research Ethics Committee.
CD14+ monocytes were purified using the RoboSep fully
automated cell separator (Stem Cell Technologies Inc) according
to manufacturer’s instructions. Purity of CD14+ cells was
determined to be greater than 98% by FACS [46].
Antibody Specificity Determination
ChIP antibodies and pre-immune antisera controls used in this
study are described in Supplementary Table S2. Dot blots for
dilution series of histone peptides (5–100 ng/ml in 20 mM Tris-
HCl, pH 7.5) containing modified histone residues or unmodified
histone control peptides (Supplementary Table S2) were prepared
by vacuum-blotting (Bio-Dot, BIO-RAD) using the Immobilon-
PSQ or Immobilon-P membranes (Millipore). Dot blots were
hybridized using standard procedures detailed elsewhere [47].
Signal intensities of hybridization signals on ECL HyperfilmTM
(GE Healthcare) were obtained and the data summarized in
Supplementary Figure S18.
Chromatin Immunoprecipitation (ChIP) and Sequential
ChIP
ChIP was performed as described elsewhere [4,48] using varying
cross-linking conditions depending on the assay (conditions
available upon request). 8–10 mg of each antibody (Supplementary
Table S2) were used in ChIP assays. Sequential ChIP (Seq-ChIP)
was performed according to the protocol found in Supplementary
Protocol S.1. Mock IP controls using the relevant pre-immune
antisera were performed for ChIP and for both rounds of Seq-ChIP.
Three bioreplicates were performed for each ChIP assay.
ChIP-chip Labelling, Microarray Hybridization and
Quantitation
Fluorescently-labelled DNA samples were prepared from unam-
plified input/ChIP/FAIRE DNAs and hybridized onto the EN-
CODE PCR product tiling array for 45 hours using an automated
hybridization station (HS 4800TM, TECAN) as described elsewhere
[4]. Microarrays were scanned using a ScanArray 4000 XL (Perkin
Elmer). Mean spot intensities from images were quantified using
ProScanArrayH Express (Perkin-Elmer) with background subtraction.
Spots affected by dust were manually flagged as ‘‘not found’’ and
excluded from subsequent analysis. These data were submitted to
ArrayExpress (accession no. E-MTAB-334).
Whole Genome ChIP-chip Analysis
Chromatin immunoprecipitated DNA samples and the input
(control) sample (see above) were amplified with a version of the
Exon-Intron Marking
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REPLI-g FFPE Kit (Qiagen) according to the manufacturer’s
protocol. 20 mg of amplified DNA of each sample was fragmented
in 16One-Phor-All Buffer plus (GE Healthcare) using 1:50
dilution of DNAse I (Epicentre) for 9 minutes at 37uC followed
by heat inactivation at 100uC for 10 minutes and snap cooling on
ice for 2 minutes. The fragmented DNA was checked on an
agarose gel to ensure that the main DNA band was below 100 bp.
The fragmented DNA was end-labeled using the GeneChip WT
Double-Stranded DNA Terminal Labeling Kit (Affymetrix)
according to the manufacturer’s protocol. 18 mg of amplified
samples were hybridized to the GeneChipH Human Tiling 2.0R
Array Set (Affymetrix) and washed, stained and scanned following
the manufacturer’s protocols. The scanned output files were
analyzed with Tiling Analysis Software version1.1 (Affymetrix,
Santa Clara, CA, USA). Probes were mapped to human
chromosomes according to NCBIv35 (hg17) genome assembly.
The samples (ChIP and genomic input samples) were normalized
together by quartile normalization using a linear intensity scale.
Two-sample analysis using only data from the perfect matches
with bandwidth 40 was applied to the sample to determine the
ChIP enrichment at each probe position. These data were
submitted to ArrayExpress (accession no. E-MTAB-336).
ChIP-sequencing
ChIP assays for histones H2B and H3 were performed in the
K562 cell line as described above. Samples were prepared for
next-generation sequencing using the Illumina ChIP-seq kit (IP-
102-1001) according to manufacturer’s instructions. Samples were
sequenced on the Genome Analyzer IIa (Illumina).
Gene Expression Analysis
We prepared total RNA from three bioreplicates of K562, U937
and CD14+ cells using TRIZOL reagent as described at http://
www.sanger.ac.uk/Projects/Microarrays/arraylab/protocol1.pdf.
RNA isolated from CD14+ monocytes was purified further using
the RNeasy MinElute Cleanup Kit following the manufacturers’
instructions (Qiagen). Each purified RNA sample was assessed for
quality and integrity using the 2100 Bioanalzyer (Agilent)
following the manufacturers’ instructions. Transcriptional activity
in K562 and U937 was determined by hybridizing samples to the
Affymetrix U133 plus 2.0 gene expression microarray and also to
the Sanger ENCODE array. For Affymetrix GeneChip analysis,
samples were prepared according to the Affymetrix GeneChip
Expression Analysis Manual (Affymetrix) using 5 mg of total RNA.
For Sanger ENCODE array analysis, labelled samples were
prepared by oligo-dT priming or random priming as described at
http://www.sanger.ac.uk/Projects/Microarrays/arraylab/protocol5.
pdf. RNA samples (labelled with Cy3) and genomic DNA (labelled
with Cy5) from the same cell source were hybridized as for ChIP-
chip analysis. Expression analysis of CD14+ monocytes was
performed using Illumina Human-6 v2 BeadChips (Illumina Inc.
San Diego, USA) [46]. Total RNA (500 ng) from each sample
was amplified and labelled by in vitro transcription according to
the manufacturer’s instructions (Illumina TotalPrep RNA ampli-
fication kit, Ambion, Texas, USA). 1500 ng of biotinylated aRNA
were hybridized, and the BeadChips washed, stained and scanned
following the manufacturer’s instructions. For each cell type
analyzed, three biological replicates were performed across the
relevant microarray platforms. Affymetrix GeneChip and Illu-
mina BeadChIP data were submitted to ArrayExpress [accession
nos. E-MTAB-335 (K562 and U937) and E-TABM-633 (CD14+
monocytes)].
For Sanger ENCODE arrays, overall gene expression levels
across all three bioreplicates were computed as the average (mean)
of the random-primed and oligodT Z-scored data mapping to the
last 2000 bases average for oligo dT-primed and random primed
normalized Cy3/Cy5 ratios for all tiles encompassing a gene.
Whole Affymetrix expression data were analyzed with Biocon-
ductor (http://bioconductor.org/), normalized and transformed
using the MAS5 and RMA methods in the affy package (http://
bioconductor.org/packages/bioc/html/affy.html). Similarly, Illu-
mina data was analyzed by RMA using the lumi (http://
bioconductor.org/packages/bioc/html/lumi.html) package. To
determine the overall expression status of genes in ENCODE
regions based on Affymetrix, Sanger ENCODE array and
Illumina analysis, expression levels of 618 annotated genes were
binned into quartiles based on RMA (Affymetrix) or Z-scores
(Sanger ENCODE arrays). Genes considered expressed (‘‘ON’’)
and non-expressed (‘‘OFF’’) were those that were found in the top
2 quartiles of ranked genes and the bottom quartile of ranked
genes respectively. Genes expressed in K562 and U937 which
were found in the intersection of quartile bins for both Affymetrix
and Sanger ENCODE array analysis (Supplementary Table S3,
S4, S5, S6) were used further. CD14+ monocyte gene ranking was
performed using RMA of Illumina data only and ‘‘ON/OFF’’
states determined using the same quartile strategy as above
(Supplementary Table S7–S8). For interpretation of whole
genome ChIP-chip datasets in the K562 cell line in the context
of gene expression, data was considered for only those genes
consistently called either absent or present by MAS5 on
Affymetrix Expression GeneChips and which also had ENSEMBL
identifiers (Supplementary Table S9). These genes were then
ranked by RMA values. Expressed and non-expressed genes were
considered to be those in the top 25% and bottom 25% of RMA
values respectively, unless specified in the text or figures.
Computational Analyses of ChIP-chip Data
(i) Pre-processing and Normalization. Pre-processed data
were created from raw enrichment data from three bioreplicate
hybridizations. The ratios of the background corrected ChIP
signal divided by the background corrected input signal, both
globally normalized to the median ratio, were used for all ChIP-
chip analyses. Ratios of duplicated spots were averaged. Ratios of
spots defined as ‘‘not found’’ and ratios with a value below zero
were excluded from the analysis and also excluded from the final
composite median data. In addition, histone modification ChIP-
chip datasets were normalized with respect to histone density
(based on averaged H3 and H2B levels) and with rabbit IgG
control datasets by dividing the final composite median data for
each ChIP-chip assay with histone density or IgG data on a tile by
tile basis. Pol II ChIP-chip datasets were normalized with mouse
IgG control datasets. Final normalized datasets were used to create
3 datasets used in the analyses: (i) centred enrichment data, (ii) log2
centred enrichment data, and (iii) log2 centred Z-scored
enrichment data (log2 centred data were divided by the
standard deviation of the entire dataset). For Affymetrix
GeneChipH tiling array experiments, the scanned output files
were analyzed with Tiling Analysis Software version1.1
(Affymetrix, Santa Clara, CA, USA). The samples (ChIP and
genomic input samples) were normalized together by quartile
normalization using a linear intensity scale. Two-sample analysis
using only data from the perfect matches with bandwidth 40 was
applied to the sample to determine the ChIP enrichment at each
probe position. All data were stored and analyzed on NCBI
human genome build 35 (hg17).
(ii) Sequential ChIP-chip (Seq-ChIP-chip). For sequential-
ChIP (ChIP for histone modifications in both rounds) and
sequential-ChIP controls (ChIP for histone modification in first
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round followed by ChIP for rabbit IgG in the second round), signal
intensities in both channels were normalized independently and
averaged for bioreplicates (based the median input signals), and then
normalized between experimental and control datasets. The signals
from each array element attributed to the sequential-ChIP
experimental datasets were obtained by subtracting signal for
each sequential ChIP control from the sequential-ChIP values in the
ChIP channel. The enrichment ratio for sequential-ChIP was then
determined relative to the normalized input channel. The ratios
were then median centred, normalized with respect to histone
density and rabbit antisera control datasets, and transformed to log2
centred Z-scored enrichment data as described above.
(iii) ChIP-sequencing. 36 bp reads were aligned to the
NCBI human genome build 36 (hg18) using the Burrows-Wheeler
alignment algorithm Bowtie [49]. 14 040 928 (H2B) and 14 896
571 (H3) unique sequence reads were aligned unambiguously to
the human genome. Aligned sequencing reads were filed into
200 bp ‘‘bins’’.
(iv) Analysis of Histone Modification Enrichments and
Gene Features. Normalized ChIP-chip and Seq-ChIP-chip
data described above was viewed within the UCSC genome
browser as formatted wiggle tracks (http://genome.ucsc.edu/
goldenPath/help/wiggle.html) permitting the visualization of
continuous-valued data in the context of annotated genome
features. Modified histone behaviours in the context of composite
genes were plotted using the R (http://www.r-project.org/) or
Python programming language. Consensus histone modification
profiles for subsets of ‘‘ON/OFF’’ genes were visualized based on
expression levels as described above.
(v) ChIP-chip and ChIP-seq Levels Across Exons and
Introns. The log2 centred Z-scored ChIP-chip and Seq-ChIP-
chip enrichment data for 19 histone modifications, five Seq-chip
combinations, histone density, FAIRE and Pol II were determined
across exon-intron gene structures for the ENCODE datasets. For
whole genome analysis, the log2 centred Z-scored enrichment data
for H3K27me1, H3K27me3, H3K36me1, H3K36me3 were
determined. For the ENCODE datasets, genes that encompassed
at least 6 kb of genomic sequence and containing three or more
exons were analyzed (see below). For whole genome analysis, in
certain situations, only the three exon constraint was used. Exon
(both canonical and alternative) and intron coordinates for genes
with Ensembl IDs were downloaded from the Ensembl database
(http://www.ensembl.org/) and associated with experimental
datasets. Canonical exons were defined as those exons present in
every annotated ENSEMBL mRNA transcript for a given
ENSEMBL gene. Alternative exons were defined as those exons
which were found in some, but not all, mRNA transcripts for a
given ENSEMBL gene. Exons (both canonical and alternative)
and introns were binned according to their position within the
transcript. Histograms of histone modification and Pol II
behaviours across consensus ‘‘ON’’ and ‘‘OFF’’ gene structures
(first ten exons and nine introns) were derived using mean ChIP-
chip or Seq-ChIP-chip enrichment/depletion values for canonical
exons and introns. The gene structure at 39 ends (last five exons
and four introns) were analyzed in a similar fashion. The mean
ChIP-chip enrichment/depletion values were also determined for
canonical and alternative exons, and for introns (with 95%
confidence intervals). For this analysis, 59 ends of genes were
considered to be the 59-most 25% of the gene, whilst gene bodies
were considered to be the remaining 75% of the gene. Sequences
containing overlap between canonical and alternative exons were
excluded from analysis. Genomic ‘‘bins’’ containing sequence
reads from ChIP-seq datasets for H2B and H3 in K562 cells, were
assigned to exons and introns in a similar fashion.
A randomization strategy (bootstrapping) was used to determine
the statistical significance of ChIP-chip and ChIP-seq distributions
across exons and introns. The genomic co-ordinates of microarray
tiles were randomized within any single dataset 100 times to
generate 100 random datasets across the ENCODE regions (or
whole genome where appropriate). This effectively assigned
datapoints, normally assigned to exons and introns, to random
genomic co-ordinates. Mean ratios were calculated for exons and
introns of consensus ‘‘ON’’ and ‘‘OFF’’ gene structures for the
experimental and random datasets based on the correct annotated
co-ordinates of exons and introns. Mean ratios from the
experimental dataset were also compared to the population of
randomized values to determine whether the mean ratios obtained
in the experimental dataset could have occurred by chance in the
randomized datasets and significance levels (P-values) were
assigned. For ChIP-seq, 100 randomized datasets were generated
for equivalent numbers of reads for both H2B and H3 (see above).
In other words, 36 bp ‘‘read’’ co-ordinates were assigned
randomly to each randomized dataset. Randomized datasets were
filed into 200 bp ‘‘bins’’ as described for the experimental datasets
(see above). Mean read levels for both exons and introns of
expressed ‘‘ON’’ genes were determined for both the experimental
and randomized datasets and P-values were assigned. Two-tailed
t-tests were also performed for pairwise comparisons of histone
modification or Pol II levels across exons (canonical) and introns in
consensus gene structures (for gene structures from exons 2R 10).
Similarly, bootstrapping and t-tests were performed at the 39 end
of genes (for the last 5 exons and 4 introns) for ChIP-chip datasets.
Supporting Information
Protocol S1 Protocol for Sequential-ChIP (Seq-ChIP) used in
this study. All reagents (including suppliers and catalogue
numbers) used for Seq-Chip assays are shown at the top of the
protocol. For details of hybridization of these samples to Sanger
Institute tiling microarrays, refer to our previous publications1,2 1.
Koch, C.M. et al. The landscape of histone modifications across
1% of the human genome in five human cell lines. Genome Res 17,
691-707 (2007). 2. Bruce, A.W., Lopez-Contreras, A., Flicek, P.,
Down, T.A., Dhami, P., Dillon, S.C., Koch, C.M., Langford,
C.F., Dunham, I., Andrews, R.M. and Vetrie, D. Functional
diversity for REST (NRSF) is defined by in vivo binding affinity
hierachies at the DNA sequence level. Genome Res 19, 994-1005
(2009).
Found at: doi:10.1371/journal.pone.0012339.s001 (2.28 MB
DOC)
Figure S1 Histone modification patterns for expressed and non-
expressed genes across the ENCODE regions in the K562 and
U937 cell lines and CD14+ monocytes. a. Consensus gene plots
for 19 histone modifications across expressed (ON) genes (n = 366).
b. Consensus gene plots for 19 histone modifications across non-
expressed (OFF) genes (n = 167). ChIP-chip enrichment levels in
both panels are expressed as mean Z-scores. Proportional gene
length and flanking regions are shown on the x axis as percentages
(%). Color key to modifications depicted in each panel are shown
to the right of the figure. Some modifications showed strong
association with 59 ends (i.e., promoters) or with gene bodies of
actively transcribed genes (with either a 59 or 39 bias). Other
modifications showed depletions across gene bodies of expressed
genes. Consensus plots for non-expressed genes exhibited the
typical hallmarks of H3K27me3 and H3K9me2 enrichments.
Found at: doi:10.1371/journal.pone.0012339.s002 (1.14 MB
TIF)
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Figure S2 Histone modification patterns for expressed and non-
expressed genes across the ENCODE regions in the K562 cell line.
a. Consensus gene plots for 19 histone modifications across
expressed (ON) genes (n = 111). b. Consensus gene plots for 19
histone modifications across non-expressed (OFF) genes (n = 53).
ChIP-chip enrichment levels in both panels are expressed as mean
Z-scores. Proportional gene length and flanking regions are shown
on the x axis as percentages (%). Color key to modifications
depicted in each panel are shown to the right of the figure. Trends
were as described in Supplementary Figure S1.
Found at: doi:10.1371/journal.pone.0012339.s003 (1.16 MB TIF)
Figure S3 Histone modification patterns for expressed and non-
expressed genes across the ENCODE regions in the U937 cell line.
a. Consensus gene plots for 19 histone modifications across
expressed (ON) genes (n = 134). b. Consensus gene plots for 19
histone modifications across non-expressed (OFF) genes (n = 62).
ChIP-chip enrichment levels in both panels are expressed as mean
Z-scores. Proportional gene length and flanking regions are shown
on the x axis as percentages (%). Color key to modifications
depicted in each panel are shown to the right of the figure. Trends
were as described in Supplementary Figure S1.
Found at: doi:10.1371/journal.pone.0012339.s004 (1.15 MB TIF)
Figure S4 Histone modification patterns for expressed and non-
expressed genes across the ENCODE regions in CD14+
monocytes. a. Consensus gene plots for 19 histone modifications
across expressed (ON) genes (n = 121). b. Consensus gene plots for
19 histone modifications across non-expressed (OFF) genes
(n = 52). ChIP-chip enrichment levels in both panels are expressed
as mean Z-scores. Proportional gene length and flanking regions
are shown on the x axis as percentages (%). Color key to
modifications depicted in each panel are shown to the right of the
figure. Trends were as described in Supplementary Figure S1.
Found at: doi:10.1371/journal.pone.0012339.s005 (1.16 MB TIF)
Figure S5 Chromatin accessibility (FAIRE) and histone density
patterns (H2B/H3) for expressed and non-expressed genes across
the ENCODE regions in the K562 and U937 cell lines and
CD14+ monocytes. a. Consensus gene plots across expressed (ON)
genes in all three cell types [ALL (n= 366), K562 (n= 111), U937
(n = 134), and CD14+ monocytes (n = 121)]. b. Consensus gene
plots across non-expressed (OFF) genes in all three cell types [ALL
(n = 167), K562 (n = 53), U937 (n= 62), and CD14+ monocytes
(n = 52)]. ChIP-chip enrichment levels in both panels are
expressed as mean Z-scores. Proportional gene length and flanking
regions are shown on the x axis as percentages (%). Color key to
FAIRE and histone density assays in each panel are shown to the
right of the figure.
Found at: doi:10.1371/journal.pone.0012339.s006 (0.88 MB TIF)
Figure S6 Histone modification patterns track exons and introns
across gene bodies without accounting for nucleosome distribu-
tion. Histograms show the mean levels of ChIP-chip enrichments
(Z-scores) for 15 histone modifications spanning the first ten exons
and nine introns of expressed consensus genes (n = 268, exons:in-
trons = 1466:551). Data is derived from ENCODE regions in the
K562 and U937 cell lines and CD14+ primary monocytes.
Datasets are not normalized with the combined histone distribu-
tion profiles obtained for H2B and H3 in each cell line.
Hypothetical gene structures are shown at the bottom of the
figure. Median P-value obtained from bootstrapping for exons and
introns across all 19 histone modifications tested in this study was
,1.0610215. Median P-value obtained for pair-wise t-tests
between adjacent exon-intron pairs (exon2 R exon10) for the data
shown in the figure was 1.1361026.
Found at: doi:10.1371/journal.pone.0012339.s007 (0.94 MB TIF)
Figure S7 Histone modification and chromatin accessibility
(FAIRE) patterns track exons and introns across gene bodies of
non-expressed genes and at 39 ends of expressed genes.
Histograms show the mean levels of ChIP-chip enrichments for
histone modifications or FAIRE values (Z-scores) spanning the first
ten exons and nine introns or last five exons and four introns of
consensus genes (hypothetical gene structures are shown at the
bottom of each panel of the figure). Data is derived from
ENCODE regions in the K562 and U937 cell lines and CD14+
primary monocytes. a. Five histone modifications across first 10
exons and 9 introns of non-expressed genes with histone
normalization (n= 92, exons:introns = 393:136). b. 14 histone
modifications and FAIRE levels across last five exons and four
introns of expressed genes with histone normalization (n= 268,
exons:introns = 848:226). c. Five histone modifications across first
ten exons and nine introns of non-expressed genes without histone
normalization (n= 92, exons:introns = 393:136). d. 14 histone
modifications and FAIRE levels across last five exons and four
introns of expressed genes without histone normalization (n= 268,
exons:introns = 848:226). Median P-values obtained from boot-
strapping for exons and introns across all patterns shown were
,1.0610215 (panel a), ,1.0610215 (panel b), ,1.0610215 (panel
c), and ,1.0610215 (panel d). Median P-values obtained for pair-
wise t-tests between adjacent exon-intron pairs were 3.1561022
(panel a), 4.4061024 (panel b), 1.3561022 (panel c), and
1.4961027 (panel d).
Found at: doi:10.1371/journal.pone.0012339.s008 (1.27 MB TIF)
Figure S8 Cell type specificity of exon-intron marking by
histone modifications cannot be accounted for by nucleosome
distributions. Histograms show the mean levels of ChIP-chip
enrichments (Z-scores) for histone modifications across exons and
introns of consensus expressed (ON) (green) or non-expressed
(OFF) genes (red). Data is derived from ENCODE regions in the
K562 and U937 cell lines and CD14+ primary monocytes and
each cell line is shown in separate panels. Histone modifications
assayed are shown along the top of the figure. Levels of histones
are also shown for each cell line at the right of the figure. Data for
each cell line is derived as follows. K562 expressed genes (n = 76,
exons/introns = 713/290), non-expressed genes (n = 25, exons/
introns = 134/76); U937 - expressed genes (n = 88, exons/introns
= 801/327), non-expressed genes (n = 20, exons/introns = 128/
75); CD14+ monocytes - expressed genes (n = 80, exons/introns
= 681/285), non-expressed genes (n = 27, exons/introns = 228/
98). All exonic levels were determined for canonical exons only.
Error bars are 95% confidence intervals.
Found at: doi:10.1371/journal.pone.0012339.s009 (1.02 MB TIF)
Figure S9 Sequential ChIP-chip enhances histone modification
tracking of exon-intron structures in the K562 cell line.
Sequential-ChIP-chip was performed using two combinations of
primary (1u, blue) and secondary (2u, red) ChIP assays which
showed exon-intron tracking across gene bodies (panels a and b).
Two control sequential ChIP-chip experiments were also per-
formed (panels c and d). In all cases, data was analyzed to take into
account nucleosome distribution (i.e., normalized with respect to
histone H2B and H3 density). a. Consensus gene plot showing
mean enrichment levels (Z-scores) across expressed (ON) (n = 111)
or non-expressed (OFF) genes (n = 53) in the K562 cell line from
ENCODE regions: 1u with anti-H3K36me3 and sequential 2u
with anti-H3K27me1 (top panel); 1u with anti-H3K27me3 and
sequential 2u with anti-H3K36me1 (bottom panel). Proportional
gene length and flanking regions are shown on the x axis as
percentages (%). b. Histograms show the levels of combinations of
Exon-Intron Marking
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histone modifications across the first ten exons and nine introns of
consensus expressed (ON) genes (n = 85, exons:introns = 499:185)
or non-expressed (OFF) genes (n = 26, exons:introns = 132:54)
from panel a. Hypothetical gene structures are shown below the
panel. Median P-values obtained from bootstrapping for exons
and introns were ,1.0610215 (expressed genes) and ,1.0610215
(non-expressed genes). Median P-values obtained for pair-wise t-
tests between adjacent exon-intron pairs (exon2 R exon10) were
3.6361024 (expressed genes) and 1.2461023 (non-expressed
genes). c. Consensus gene plot showing mean enrichment levels
(Z-scores) across expressed (ON) (n = 111) genes in the K562 cell
line from ENCODE regions: 1u with anti-H3K27me1 and
sequential 2u with anti-H3K36me3 (top panel); 1u with anti-
H3K4me3 and sequential 2u with anti-H3K9me3 (bottom panel).
d. Histograms show the levels of combinations of histone
modifications across the first ten exons and nine introns of
consensus expressed genes (ON) (n = 85, exons:introns = 499:185)
from panel c. Hypothetical gene structures are shown below the
panel. The first control sequential ChIP-chip (H3K27me1 R
H3K36me3) was used to demonstrate that sequential ChIP-chip
gave the same result irrespective of which antibody was used first
(see panels a and b for reversed combination). The second control
sequential ChIP-chip (H3K4me3R H3K9me3) was used to show
a decrease in exon-intron marking for two modifications which
showed opposing exon-intron biases (H3K4me3 = exon enrich-
ment bias; H3K9me3 = exon depletion bias). Median P-values
obtained from bootstrapping for exons and introns were
,1.0610215 (H3K27me1 R H3K36me3 combination) and
,1.0610215 (H3K4me3 R H3K9me3 combination). Median P-
values obtained for pair-wise t-tests between adjacent exon-intron
pairs (exon2 R exon10) were 6.79610
25 (H3K27me1 R
H3K36me3 combination) and 0.16 (H3K4me3 R H3K9me3
combination). Thus, exon-intron tracking for this latter combina-
tion was no longer statistically significant.
Found at: doi:10.1371/journal.pone.0012339.s010 (0.85 MB TIF)
Figure S10 Histograms show the levels of sequential-ChIP-chip
enrichments for combinations of histone modifications (those
described in Figure S9) spanning typical canonical/alternatively-
spliced exons (CE and AE respectively) and introns (I) of expressed
genes [n = 85, canonical exons:alternatively-spliced exons:introns
= 145:68:221 (59 ends) or 796:166:976 (gene bodies)]. Blue bars
show ChIP-chip enrichments after 1u antibody and red bars show
ChIP-chip enrichment after the 2u antibody. Error bars are 95%
confidence intervals. In all panels, histone modification ChIP-chip
enrichment levels are expressed as mean Z-scores.
Found at: doi:10.1371/journal.pone.0012339.s011 (0.84 MB
TIF)
Figure S11 Histone modifications differentially mark canonical
and alternatively-spliced exons and introns across non-expressed
genes. Histograms show the mean levels (Z-scores) for histone
modifications and histones (ChIP-chip enrichments) or chromatin
accessibility (FAIRE) spanning typical canonical/alternatively-
spliced exons and introns. Data was derived from gene bodies of
non-expressed genes (n = 92, canonical exons:alternatively-spliced
exons:introns = 631:184:826) in the K562 and U937 cell lines and
CD14+ primary monocytes across the ENCODE regions. Histone
distribution was based on the combined data for H2B and H3 in
each cell type. Biases favoring either canonical exon or intron are
summarized by the difference in Z-scores shown above each assay
in grey. Positive (+) differences in Z-scores reflect exon biases,
while negative (2) differences reflect intron biases. Error bars are
95% confidence intervals.
Found at: doi:10.1371/journal.pone.0012339.s012 (0.76 MB TIF)
Figure S12 FAIRE accessibility assays show introns are
preferentially accessible across three cell types. Histograms show
the mean levels of FAIRE enrichments (Z-scores) across exons and
introns of consensus expressed (ON) (green) or non-expressed
(OFF) genes (red). Data is derived from ENCODE regions in the
K562 and U937 cell lines and CD14+ primary monocytes and
each cell line is shown separately. Datapoints for each cell line
were derived as follows. K562 expressed genes (n = 76, exons/
introns = 713/290), non-expressed genes (n = 25, exons/introns
= 134/76); U937 - expressed genes (n = 88, exons/introns = 801/
327), non-expressed genes (n = 20, exons/introns = 128/75);
CD14+ monocytes - expressed genes (n = 80, exons/introns
= 681/285), non-expressed genes (n = 27, exons/introns = 228/
98). All exonic levels were determined for canonical exons only.
Error bars are 95% confidence intervals.
Found at: doi:10.1371/journal.pone.0012339.s013 (0.50 MB TIF)
Figure S13 RNA polymerase II (Pol II) occupancy levels are not
accounted for by nucleosome distributions. Histograms show the
mean levels of ChIP-chip enrichments (Z-scores) for Pol II and
histones across exons and introns of consensus expressed (ON)
(green) or non-expressed (OFF) genes (red). a. Data derived from
ENCODE regions in the K562 cell line: expressed genes (n = 76,
exons/introns = 707/287), non expressed genes (n = 25, exons/
introns = 133/76). b. Data derived from U937 cell line: expressed
genes (n = 88, exons/introns = 797/325), non expressed genes
(n = 20, exons/introns = 123/73). All exonic levels were deter-
mined for canonical exons only. Error bars are 95% confidence
intervals.
Found at: doi:10.1371/journal.pone.0012339.s014 (0.52 MB TIF)
Figure S14 Genome-wide patterns of H3K27me1, H3K27me3,
H3K36me1 and H3K36me3 for expressed and non-expressed
genes in the K562 cell line. a. Consensus gene plots for four
histone modifications across expressed (ON) genes (n = 2066). b.
Consensus gene plots for four histone modifications across non-
expressed (OFF) genes (n = 1973). ChIP-chip enrichment levels in
both panels are expressed as mean Z-scores. Proportional gene
length and flanking regions are shown on the x axis as percentages
(%). Color key to modifications depicted in each panel are shown
to the right of the figure.
Found at: doi:10.1371/journal.pone.0012339.s015 (0.60 MB TIF)
Figure S15 Histone modifications patterns mark exon-intron
structures across the whole human genome. a. Histograms show
the level of H3K27me1 (bin 0%-10%, n=662, exon:introns =
4378:3697) and H3K36me3 (bin 0%–25%, n=1657, exon:in-
trons = 10911:9194) across the first ten exons and nine introns of
consensus non-expressed (OFF) genes. Exon numbering is at the
bottom of panel. b. Histograms show the levels of ChIP-chip
enrichments for H3K27me3 [bin 95%–100%, n=332, canonical
exons:alternatively-spliced exons:introns = 642:165:811 (59 ends)
or 2415:402:2817 (gene bodies)] and H3K36me1 [bin 90%–
100%, n= 700, canonical exons:alternatively-spliced exons:in-
trons = 1385:400:1803 (59 ends) or 5750:882:6649 (gene bodies)]
spanning typical canonical (dark green)/alternatively-spliced (light
green) exons and introns (olive green) of expressed (ON) genes.
Error bars are 95% confidence intervals. In both panels, ChIP-
chip enrichments obtained from genome-wide analysis of the
K562 cell line are expressed as mean Z-scores.
Found at: doi:10.1371/journal.pone.0012339.s016 (0.51 MB TIF)
Figure S16 Histone modification patterns show relationships
with either exon inclusion or with exon exclusion within gene
bodies of highly expressed genes. Histograms show the levels of
four histone modifications for the top ten percent of expressed
Exon-Intron Marking
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genes in the K562 cell line. Genes (991) were placed into two bins:
90–95% and 95%–100% based on ranked expression level.
Analysis shown was based on canonical exons = 6967, introns
= 7714, and alternatively-spliced exons 221: 1040 (0–50%
inclusion: 50–100% inclusion). Error bars are 95% confidence
intervals. In all panels, ChIP-chip enrichments obtained from
genome-wide analysis of the K562 cell line are expressed as mean
Z-scores.
Found at: doi:10.1371/journal.pone.0012339.s017 (0.93 MB TIF)
Figure S17 Changes in gene expression levels are accompanied
by changes in histone modification levels across gene bodies.
Levels of H3K36me3, H3K27me1, H3K36me1, and H3K27me3
for genes which show differential expression between cell types
(K562, U937 and CD14+) are shown. Histone modification ChIP-
chip enrichment levels (Z-scores) for canonical exons (red) and
introns (green) are shown on the y axis. Gene names and their
expression levels in two different cell types (level of expression - low
R high or off R on - denoted by the black triangle) are shown
below the x axis. H3K36me3 and H3K27me1 both show exon
enrichment biases for all differentially-expressed gene pairs shown.
However, both H3K36me1 and H3K27me3 show either exon or
intron enrichment biases depending on the level of gene
expression, which are consistent with the whole genome datasets
shown in Figure 5. Error bars are 95% confidence intervals.
Found at: doi:10.1371/journal.pone.0012339.s018 (1.13 MB TIF)
Figure S18 Determination of specificity of antibodies used in
this study by dot blot analysis. Antibodies raised against histone
modifications were each hybridized to a panel of relevant methyl-
modified or acetyl modified peptides of histone H3 and histone H4
and their unmodified forms (see also Materials and Methods).
Antibodies (Ab) and peptides (Pep) used are shown on the left and
top of each panel respectively. Images in each panel are
composites of different hybridizations denoted by the black lines
dividing the sections of the panels. a. H3K9 methyl modifications.
b. H3K36 methyl modifications. c. H3K27 methyl modifications.
d. H3K79 methyl modifications. e. H3K9, 18, 27 acetyl
modifications. f. H3K4 methyl modifications. g. H4K16 acetyl
modification. In all panels, the results are shown for peptides
spotted onto the immunoblot at a concentration of 25 ng/ml.
Found at: doi:10.1371/journal.pone.0012339.s019 (1.44 MB TIF)
Table S1 Concordance of histone modification exon-intron
marking biases between cell types. Table shows level of agreement
in exon-intron marking biases for K562, U937 cell lines and
CD14+ primary monocytes. Histone modifications are shown in
columns along the top. Pairwise comparisons between cell lines are
shown along the left-hand side. Each black box shows when the
exon-intron marking bias for a histone modification (either an
exon or intron bias) is in agreement between two cell types for
either expressed (ON) (green boxes) or non-expressed (OFF) (red
boxes) genes. White boxes represent discordance. Concordance
was scored based on the data presented in Supplementary Figure
S8. Overall concordance between all three cell types is shown in
the bottom row of the table.
Found at: doi:10.1371/journal.pone.0012339.s020 (0.02 MB
DOC)
Table S2 Antibodies and peptides used in this ChIP-chip study.
a. The name of the epitopes to which each antibody used in ChIP-
chip is given in the first column. The supplier and the catalogue
number of each antibody are given in the second and third
columns respectively. Lot numbers of each antibody appears in the
last column. b. The names of peptides used in dot blot analysis are
shown in the first column. The supplier and the catalogue number
of each peptide are given in the second and third columns
respectively.
Found at: doi:10.1371/journal.pone.0012339.s021 (0.08 MB
DOC)
Table S3 Expressed genes in the K562 cell line across the
ENCODE regions. Expressed genes were determined as described
in Materials and Methods and this list reflects the intersecting top
two quartiles of expression values obtained from Affymetrix
GeneChipH and Sanger Institute microarray expression studies.
Gene ID/name is shown in the first column. The ENCODE
region, chromosome co-ordinates [(NCBI human genome build
35 (hg17)] and direction of transcript/strand are also shown in the
additional columns.
Found at: doi:10.1371/journal.pone.0012339.s022 (0.50 MB
DOC)
Table S4 Non-expressed genes in the K562 cell line across the
ENCODE regions. Non-expressed genes were determined as
described in Materials and Methods and this list reflects the
intersecting bottom quartile of expression values obtained from
Affymetrix GeneChipH and Sanger Institute microarray expres-
sion studies. Gene ID/name is shown in the first column. The
ENCODE region, chromosome co-ordinates [(NCBI human
genome build 35 (hg17)] and direction of transcript/strand are
also shown in the additional columns.
Found at: doi:10.1371/journal.pone.0012339.s023 (0.24 MB
DOC)
Table S5 Expressed genes in the U937 cell line across the
ENCODE regions. Expressed genes were determined as described
in Materials and Methods and this list reflects the intersecting top
two quartiles of expression values obtained from Affymetrix
GeneChipH and Sanger Institute microarray expression studies.
Gene ID/name is shown in the first column. The ENCODE
region, chromosome co-ordinates [(NCBI human genome build
35 (hg17)] and direction of transcript/strand are also shown in the
additional columns.
Found at: doi:10.1371/journal.pone.0012339.s024 (0.57 MB
DOC)
Table S6 Non-expressed genes in the U937 cell line across the
ENCODE regions. Non-expressed genes were determined as
described in Materials and Methods and this list reflects the
intersecting bottom quartile of expression values obtained from
Affymetrix GeneChipH and Sanger Institute microarray expres-
sion studies. Gene ID/name is shown in the first column. The
ENCODE region, chromosome co-ordinates [(NCBI human
genome build 35 (hg17)] and direction of transcript/strand are
also shown in the additional columns.
Found at: doi:10.1371/journal.pone.0012339.s025 (0.29 MB
DOC)
Table S7 Expressed genes in CD14+ monocytes across the
ENCODE regions. Expressed genes were determined as described
in Materials and Methods and this list reflects the top two quartiles
of expression values obtained from Illumina BeadChipH expres-
sion studies. Gene ID/name is shown in the first column. The
ENCODE region, chromosome co-ordinates [(NCBI human
genome build 35 (hg17)] and direction of transcript/strand are
also shown in the additional columns.
Found at: doi:10.1371/journal.pone.0012339.s026 (0.51 MB
DOC)
Table S8 Non-expressed genes in CD14+ monocytes across the
ENCODE regions. Non-expressed genes were determined as
described in Materials and Methods and this list reflects the
Exon-Intron Marking
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bottom quartile of expression values obtained from Illumina
BeadChipH expression studies. Gene ID/name is shown in the first
column. The ENCODE region, chromosome co-ordinates [(NCBI
human genome build 35 (hg17)] and direction of transcript/strand
are also shown in the additional columns.
Found at: doi:10.1371/journal.pone.0012339.s027 (0.27 MB
DOC)
Table S9 Expression levels of 9922 genes across the human
genome in the K562 cell line. These genes gave consistent MAS5
values (all A or all P) in four bioreplicate Affymetrix GeneChIPH
expression experiments and all had been assigned ENSEMBL
identifiers. List shows their ENSEMBL IDs, MAS5 call and
ranking based on RMA values.
Found at: doi:10.1371/journal.pone.0012339.s028 (0.36 MB
TXT)
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